Hera Med Ltd
ASX:HMD

Watchlist Manager
Hera Med Ltd Logo
Hera Med Ltd
ASX:HMD
Watchlist
Price: 0.039 AUD -2.5% Market Closed
Market Cap: 40.7m AUD

Hera Med Ltd
Investor Relations

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Ms. Sivan Sadan
Executive Vice President
No Bio Available
Ms. Anoushka Gungadin
MD, CEO & Director
No Bio Available
Mr. Cameron Jones C.A.
CFO & Company Secretary
No Bio Available
Henry Jordan
Head of Investor Relations
No Bio Available

Contacts

Address
Netanya
6 Meir Ariel Street, Pob 8576
Contacts